# Johnson & Johnson (JNJ) — Q3-2009 Earnings Results

**Report date:** 2009-10-13 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2009

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.20 | N/A | +6.10% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's ability to navigate market challenges. They highlighted ongoing investments in innovation as a key growth driver.

**Key quotes:**

> We remain focused on our core business strengths.

> Innovation continues to drive our growth strategy.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, without revenue data or stock reaction details, it's unclear how the market responded. The management's focus on innovation suggests a commitment to growth despite potential challenges ahead.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2009_